Eur Rev Med Pharmacol Sci 2019; 23 (2): 771-787
DOI: 10.26355/eurrev_201901_16892

Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century

D. Pagliari, M.G. Brizi, A. Saviano, F.A. Mancarella, A.A. Dal Lago, M.L. Serricchio, E.E. Newton, F. Attili, R. Manfredi, A. Gasbarrini

Division of Internal Medicine and Gastroenterology & Pancreatic Unit, Fondazione Policlinico Universitario A. Gemelli – IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. danilo.pagliari@gmail.com


Acute pancreatitis (AP) is the most common gastrointestinal disorder requiring hospitalization, with a high rate of morbidity and mortality. Severe AP is characterized by the presence of persistent organ failure involving single or multiple organs. Clinical evolution, laboratory and radiological assessment are necessary to evaluate the prognosis and inform the management of AP. The onset of severe AP may be classified in two principal phases. The early phase, during the first week, is characterized by the activation of the auto-inflammatory cascade, gut dysbiosis, bacterial translocation, and the down-regulation of immune responses. The late phase is characterized by the development of local and systemic complications. Several old paradigms have been amended in the management of AP patients, such as the indication of nutrition, the use of antibiotic therapy, pain control strategies, and even the use of surgery. Real world evidence has shown that in the majority of cases a step-up approach is most effective. In this review, we discuss the clinical assessment and improvements to the management of patients with severe AP in a high volume center where a multi-disciplinary approach is performed.

Free PDF Download

To cite this article

D. Pagliari, M.G. Brizi, A. Saviano, F.A. Mancarella, A.A. Dal Lago, M.L. Serricchio, E.E. Newton, F. Attili, R. Manfredi, A. Gasbarrini
Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 2
Pages: 771-787
DOI: 10.26355/eurrev_201901_16892